SCHEMBL17219035

SCHEMBL17219035

N#Cc1ccccc1[C]=NOCc1ccccc1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.42
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTR2A P28223 1/20 0.36
MCL1 Q07820 1/20 0.36
RAB9A P51151 2/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 3/20 0.36
PIK3CG P48736 1/20 0.35
KCNH2 Q12809 1/20 0.35
MAOB P27338 3/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
TAAR1 Q96RJ0 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17219033 1.00 IDO1 (0.42) IDO1TDP1L3MBTL1HTR2AMCL1
SCHEMBL17215884 0.90 HTR2A (0.34) IDO1TDP1L3MBTL1HTR2ARAB9A
SCHEMBL17215883 0.90 HTR2A (0.34) IDO1TDP1L3MBTL1HTR2ARAB9A
SCHEMBL17218000 0.88 KMT2A (0.41) IDO1TDP1L3MBTL1HTR2ARAB9A
SCHEMBL17217997 0.88 KMT2A (0.41) IDO1TDP1L3MBTL1HTR2ARAB9A
SCHEMBL17219190 0.87 IDO1 (0.47) IDO1MCL1MEN1KMT2AALDH1A1
SCHEMBL17217987 0.87 RAB9A (0.44) TDP1RAB9AHTTMEN1NPC1
SCHEMBL17219192 0.87 IDO1 (0.47) IDO1MCL1MEN1KMT2AALDH1A1
SCHEMBL17217989 0.87 RAB9A (0.44) TDP1RAB9AHTTMEN1NPC1
SCHEMBL17216638 0.86 MAPK14 (0.43) IDO1TDP1HTR2ARAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940012-B1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-30 EP disclosed
US-9560850-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-07 US disclosed
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 US disclosed
EP-2940012-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF Sumitomo Chemical Company Limited (JP) 2015-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF RTN3, CYP51A1, TCOF1 IDO1 2882/4885TDP1 3489/4885L3MBTL1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.